Uniting payors, providers, and pharmacies for seamless care.
53M+
Members supported
100%
Compliance Rate
- Strategy
- Web
- App
Ailoitte is a regulatory document automation company. We build AI that writes first drafts of clinical, submission, device and quality documents from your own data and templates. Each statement links back to its source. Each action is logged for Part 11. And a qualified writer signs off every page. The draft is automated. The accountability is not.
Tell us the document, your markets and where time is lost. Within a week: whether it is a good fit, what QA will need, and the fixed price.
Traceable to source
Each line links to the data behind it.
Affordable by design
Fixed price from $4,000 per document type.
Validation-ready
We hand over the proof QA needs.
Trial documents, filing content, device files and quality records. It writes them from your own data, your templates and past approved work.
Your writers. They check, fix and sign every page. Their job moves from writing first drafts to making them better.
A pilot for one document type in 4 to 6 weeks, and several types in 10 to 16. Your QA work runs alongside from week one.
A fixed price per document type, from $4,000 to $39,000 by scope and AI use, quoted after a free audit. No fee per page or per filing.
We build it to be validated and hand over a CSA-aligned evidence package. Your quality assurance team performs and owns the validation.
The code, prompts, settings, test sets and proof pack are yours once paid. Your data and drafts stay in your own systems.
AI regulatory document generation writes first drafts of regulated documents from your own data, templates and past work, then sends them to a qualified person to review. A team of AI agents does the slow, repetitive part. It finds the right data, follows the template, keeps cross-references and numbers right, and flags anything that does not match before a person reads it.
Regulators treat help with writing differently from AI that shapes a decision. FDA’s January 2025 draft guide on AI in drug work sets out a seven-step test of trust. It leaves out tools that save time without touching patient safety, drug quality or study results (Goodwin, on the FDA draft guidance). In January 2026, EMA and FDA added ten shared principles for good AI practice. They rest on human oversight, a defined context of use and risk-based validation (RAPS).
Either way, the sponsor still answers for every word it files. That is the core of our AI regulatory document generation services. Your writers stay the named authors. The system just gives them a draft they can trace and improve, in place of a blank page.
Send one example with names removed. We will tell you how much of it repeats, and how much of the drafting we could take off your team.
Both are strict, structured and repeated often. But they answer to different rules and different reviewers. Drug makers, CROs and biotechs often start with trial documents. Device makers often start with quality records, where the shape repeats most and the payback comes first.
The problem: a fixed filing date and too few writers.
The problem: the same structure, rewritten by hand.
The problem is rarely how well people write. It is the slow work around the writing, and the weeks it eats.
| Step | Today | With automated drafting |
|---|---|---|
| The first draft | Senior writers piece it together by hand from tables and old files. | A draft arrives with every line linked to its source. |
| Cross-references | Hundreds kept by hand, and errors show up at review. | Kept in sync and checked again each time the draft is rebuilt. |
| Source data changes | Each linked document found and fixed by hand. | The sections it touches are flagged and redrafted for the writer. |
| Review | Reviewers spend their time on numbers and wording. | Reviewers spend their time on science and risk. |
| Inspection | Working out who wrote what, from which data, takes days. | The log shows the source, the model, the writer and who signed. |
Four steps, and the last one is the point. In a filing, a claim with no source is a finding, not a typo. So the system flags a gap instead of making text up. And a qualified writer signs every section before it becomes a record.
Each type needs a structured template, a defined source of truth, and enough precedent to learn your house conventions. Final eCTD publishing and submission checks stay with your publishing team.
Protocols, site brochures, study reports and patient narratives. For most sponsors, this is the biggest writing load.
Content built to the CTD layout, with links and numbers kept right from one section to the next.
Technical files, clinical evaluation reports and safety follow-up reports under EU MDR and IVDR.
Deviation reports, CAPA records and test summaries. The shape repeats, so they often pay back first.
Drafted and updated when your process changes, with each change traced and signed.
Draft replies to questions from regulators, based on what you filed and earlier letters.
Send the document types, how many you write a year and your team size. We will measure your own baseline in the audit.
A pilot for one document type in 4 to 6 weeks, and several types in 10 to 16. Your QA team’s work is planned in from week one, not left as a gate at the end. Delivered on Clarity, our delivery method.
We review your documents, templates and data. We find what truly repeats, where link errors happen, and how long drafts take today.
We define what each function is for, give it a GAMP 5 class and a risk level, agree the test scope with QA, and map where Part 11 applies.
The agents read from your trusted data, follow your templates and house style, and log every step from the first line of code.
We draft from old source data and compare the result with what was approved. We check that gaps get flagged, and sort errors with your writers.
One live document type with full human review. We measure results against your baseline and build the proof pack for QA. Then you decide go or no-go.
If a partner has not raised validation before you did, that is a warning sign. We raise it in the first call, sort each function by risk, and build so your QA team can sign it off with the proof we hand over.
Software used in making a product or running the quality system must be tested for the job it does. For US devices, the quality rule has matched ISO 13485 since 2 February 2026 (IntuitionLabs). For medicines in Europe, EU GMP Annex 11 applies.
FDA made its Computer Software Assurance guide final in September 2025. It replaces long scripted tests with checks sized to the risk, and it includes a cloud software example (Kneat).
A drafting function carries different expectations from one that writes to a regulated record. We classify every function by risk at design time, so the assurance scope is known before the build.
Intended use statements, risk classification, design and configuration specifications, test evidence, a traceability matrix and change records. Your quality assurance team performs and owns the validation.
We design against 21 CFR Part 11, EU GMP Annex 11, ICH Q9 and Q10, GAMP 5 Second Edition and ALCOA+, and your quality assurance team confirms which apply. See security and compliance and private AI deployment for systems that must run entirely inside your own tenancy.
Compliance records and clinical notes share the hard parts of regulated writing: strict templates, a defined source of truth, a complete audit trail, and a qualified person who signs. See ROI case studies.
A document type costs $4,000 to $39,000, fixed, based on scope and how much AI it needs. A quality record with a stable template sits near the low end. A study report that pulls from many data sources, with DMS links and private hosting, sits near the top.
The price moves with the number of sources, templates and markets, and how much proof QA needs. Running costs such as AI use and hosting are listed on their own. Larger programs can run as an AI Velocity Pod from about $15,000 a month.
Drafts land in your document system with tags and sign-off steps in place. Your writers do not need to check a second tool.
Veeva Vault, MasterControl, Documentum or SharePoint, set up per project.
Trial master files, with tags and sign-off steps kept in place.
Tables and figures from your statistics team.
Clean content passed to your eCTD publishing tool.
Part 11 sign-off steps with named signatures.
Deviation, CAPA and change records.
Your choice of provider, set never to train on your data.
Open models in your cloud or on site when data cannot leave.
Building a system that drafts regulated documents from your own source data, templates and precedent, then routes them to qualified reviewers. Agents retrieve the data, apply the template, keep cross-references consistent and flag gaps. Your writers review, correct and approve.
A working drafting system, its audit trail, and the evidence package your QA team needs to validate it. We build into your document management system and hand over code, configuration and test sets, so your team can run it without us.
No. It replaces the blank page and the mechanical assembly work. Writers move from producing first drafts to reviewing and improving them, and remain the named, accountable authors.
Yes, if it is used in production or the quality system. It is a GxP computer system and must be validated for its intended use. We build it to be ready to validate and deliver the evidence package; your quality team performs and owns the validation.
FDA’s risk-based framework for assuring production and quality system software, finalized in September 2025. It replaces exhaustive scripted testing with assurance proportionate to risk, so a drafting function needs less than one that writes a regulated record.
Grounding, traceability and refusal. Statements come only from your source documents, each carries a link back to its data, and the system flags a gap rather than filling it. We test that deliberately before any pilot.
It is designed for Part 11 from the start. Every generation event is logged with user, time, source and change reason, approvals carry attributable electronic signatures, and we supply IQ and OQ documentation to support your validation.
21 CFR Part 11, FDA CSA and device quality rules in the US; EU GMP Annex 11, EU MDR and IVDR in Europe; ICH Q9 and Q10, GAMP 5 Second Edition and ALCOA+ across both. Your quality team confirms which apply.
Clinical, submission, device and quality documents. Protocols, investigator brochures, study reports, patient narratives, CTD module content, technical files, clinical evaluation and surveillance reports, deviations, CAPA records, validation summaries and SOPs.
It generates content aligned to CTD module structure and keeps cross-references consistent. Whether it writes into your publishing tool or hands off structured content depends on the tool, and final submission validation stays with your publishing team.
Yes. We build integration with Veeva Vault, MasterControl, Documentum, SharePoint and eTMF platforms, so drafts arrive with metadata and approval workflows intact. Each connector is scoped per project.
A working pilot for one document type in 4 to 6 weeks. Several document types take 10 to 16 weeks, with your validation activities planned in from week one.
Between $4,000 and $39,000 per document type, fixed, depending on scope and the AI involved. Running costs such as AI usage and hosting are listed separately. We quote after a free document audit.
No, and be cautious of vendors who do. Accuracy depends on your document type, source data and templates. We measure your baseline in the audit and report against it during the pilot, with the method stated so QA can assess it.
Yes, and in this sector it often must. We deploy open models inside your tenancy or on-premise, so no regulated content leaves your environment, and your content never trains outside models.
Send it over. A regulated AI lead replies within 12 hours.
Tell us the document type, your submission markets and where the calendar is lost. A senior architect will tell you whether it is a good candidate, what the assurance scope looks like, and which document types we would leave alone.
Loading available times…
Information Security
Management System
Quality Management
System
Response guaranteed within 12 hours.



A senior engineer will review your brief and reply within 12 hours. Want to talk sooner? Pick a time that suits you.
Book a 30-minute call